Merck & Co., Inc. Employee Count
The employee counts Merck & Co., Inc. states in its annual reports on SEC EDGAR, each as filed.
- 2025-12-31: Employees (as filed) 75,000; Filing 2026-02-24; Lease expense per employee $5,640.00.
- 2024-12-31: Employees (as filed) 75,000; Filing 2025-02-25; Lease expense per employee $4,640.00.
- 2023-12-31: Employees (as filed) 72,000; Filing 2024-02-26; Lease expense per employee $4,708.33.
- 2022-12-31: Employees (as filed) 69,000; Filing 2023-02-24; Lease expense per employee $4,840.58.
- Available history
- 2009-12-31 to 2025-12-31
Historical Employee Count
| Date | Employees (as filed) | Filing | Lease expense per employee |
|---|---|---|---|
| 2025-12-31 | 75,000 | 2026-02-24 | $5,640.00 operating |
| 2024-12-31 | 75,000 | 2025-02-25 | $4,640.00 operating |
| 2023-12-31 | 72,000 | 2024-02-26 | $4,708.33 operating |
| 2022-12-31 | 69,000 | 2023-02-24 | $4,840.58 operating |
| 2021-12-31 | 68,000 | 2022-02-25 | $5,044.12 operating |
| 2020-12-31 | 74,000 | 2021-02-25 | $4,594.59 operating |
| 2019-12-31 | 71,000 | 2020-02-26 | $4,690.14 operating |
| 2018-12-31 | 69,000 | 2019-02-27 | $4,666.67 rent expense, net |
| 2017-12-31 | 69,000 | 2018-02-27 | $4,739.13 rent expense, net |
| 2016-12-31 | 68,000 | 2017-02-28 | $4,294.12 rent expense, net |
| 2015-12-31 | 68,000 | 2016-02-26 | $4,455.88 rent expense, net |
| 2014-12-31 | 70,000 | 2015-02-27 | $5,000.00 rent expense, net |
| 2013-12-31 | 76,000 | 2014-02-27 | $4,828.95 rent expense, net |
| 2012-12-31 | 83,000 | 2013-02-28 | $4,771.08 rent expense, net |
| 2011-12-31 | 86,000 | 2012-02-28 | $4,779.07 rent expense, net |
| 2010-12-31 | 94,000 | 2011-02-28 | $4,585.11 rent expense, net |
| 2009-12-31 | 100,000 | 2010-03-01 | $2,370.00 lease and rental expense |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |